Sample Letter

________________________________

Your Name

________________________________

Address

________________________________

City, State, Zip

Date____________________________

 

 

 

 

Honorable Senator  ________________

United States Senate

Washington, DC  20515

Dear Senator _____________________:

On February 11, 1999 Senator McCain introduced S423 the Addiction Free

Treatment Act. This legislation was intended as a political assault
on the

Office of National Drug Control Policy (ONDCP) and General (ret)

McCaffreys statement that methadone maintenance should be expanded.

Instead it was demeaning to thousands of current and former methadone

patients to have the personal bias can prejudice contained within read
on

the floor of the U. S. Senate. It was a demonstration of no regard
for the

harm caused to individuals who have struggled to regain their lives
from a

self promoting legislator.

Methadone maintenance has restored the lives of hundred of thousands
of

addicts once considered incorrigible and hopeless. The majority of

methadone patients have proven themselves capable and successful in
the

practical world, as lawyers and waitresses, construction workers and

housewives, teachers and cab drivers. Methadone maintenance is the
greatest

success story waiting to be told: restoring families and giving hope
to the

hopeless.

To not consult the vast wealth of scientific research is an affront
to the

American taxpayers who have paid for it.  It is odd that a public
official

would not consult the National Institute on Drug Abuse (NIDA) and Center

for Substance Abuse Treatment (CSAT) whose cutting edge research have

provided scientific evaluations that are utilized throughout the world.

Senate Bill 423 contains consistent bias, falsehoods and wishful thinking.

Legislation should be based on sound scientific analysis and facts
and not

reflect the hearsay of a self-adulator or ones personal bias. In

particular the National Alliance of Methadone Advocates takes offense
to:

(1) In Section 2 (5) the statement that methadone results in the transfer

of addiction is scientifically incorrect, blurs the true meaning of

addiction and is stigmatizing to methadone patients by equating them
to the

illicit addict. (2) Section 2 (6) equates heroin and Methadone Withdrawal

which is another serious error and the assumptions made about withdrawal
as

the primary treatment for addiction is wrong. (3)  Section 2 (7)
will halt

several new effective chemotherapys and thus wasting research conducted
at

the taxpayers expense. This section if passed will place the United
States

back into the 1950s when abstinence was the only treatment for opiate

addiction and a failure as over 90% would relapse. (4) Sections 3 and
4

interferes with the ability of experts who have undergone years of
training

to treat addiction. Furthermore, many of the conditions set forth in
this

section are already guidelines within the program. Other statements
are

dangerous to the public health by discharging individuals who have
come for

help for their addiction, including pregnant addicts, the HIV/TB infected,

the mentally ill and the poly-addicted.  (5) Section 5 will spend
duplicate

monies on research that is already being conducted to evaluate treatment

Methadone patients are heroes and their struggles to regain their lives
and

their families should not be diminished by legislation that is intended
to

harm and stigmatize. They have fought to regain their humanity against

difficult odds including prejudice and stigma and to belittle and demean

them on the floor of the U.S. Senate is contemptible..

It is unethical to use legislation as an instrument for self promotion.

NAMA opposes this legislation as an instrument of bias and prejudice
that

will create havoc to the lives of those who have been stable and productive

and destructive to those who need treatment now or may in the future.
We

ask that you support the ONDCP and General McCaffreys work to expand

methadone maintenance treatment so that it is available to all who
may need

it.

 

(Write your letter here)

 

 

Thank you, Respectfully.

_______________________________________

Your Signature

 

 

 

Similar Posts

  • JUDGE RULES AGAINST METHADONE CLINIC JOSEPH D. BRYANT News staff writer

    Admin 11/07/2021

    Birmingham News (Alabama), October 15, 2004 Friday. Shelby County’s first proposed methadone clinic won’t be allowed to open after a judge ruled that nearby residents were misled about the owners’ intentions. Shelby County Circuit Judge Dan Reeves granted a permanent injunction Thursday against the Shelby County Treatment Center on U.S. 31 in Saginaw. Reeves’ order…

  • At ATTOD

    Admin 02/19/2022

    Methadone Advocate Training   Want to know what a Methadone Conference is like? Check out our report on the NAMA website methadone.org                         FIRST EVER METHADONE (MAT) ADVOCATE TRAINING AND CERTIFICATION AT THE 2003 AATOD CONFERENCE IN Washington, DC SATURDAY APRIL 12, 2003 Information about the first ever CMA Training at AATOD on April 12,…

  • Tag: patient rights

    Admin 11/08/2021

    DOJ publishes guidance on Opioid Use Disorder and the Americans with Disabilities Act April 15, 2022 “The opioid crisis poses an extraordinary challenge to communities throughout our country. The Department of Justice (the Department) has responded with a comprehensive approach prioritizing prevention, enforcement, and treatment. This includes enforcing the Americans with Disabilities Act (Ada), which…

  • |

    42 Code of Federal Regulations Part 8 Opioid Treatment Programs Certification

    Admin 02/28/2022

    Title 42–Public Health CHAPTER I–PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES PART 8–CERTIFICATION OF OPIOID TREATMENT PROGRAMS Subpart A–Accreditation Sec. 8.1   Scope. 8.2   Definitions. 8.3   Application for approval as an accreditation body. 8.4   Accreditation body responsibilities. 8.5   Periodic evaluation of accreditation bodies. 8.6   Withdrawal of approval of accreditation bodies. Subpart B–Certification and Treatment Standards 8.11   Opioid treatment program certification. 8.12   Federal…

  • The Advocacy Training Session

    Admin 12/18/2021

      The first training for certification will include a variety of topics to give advocates a well-grounded understanding of methadone treatment, research, regulations and laws that protect methadone patients and programs.   Addiction and Methadone– Tom Payte, MD (Drug Dependence Associates) and Joycelyn Woods, MA. (NAMA) The biological constructs of addiction will be explained in…

  • TEXNAMA

    Admin 08/25/2021

    Texas Alliance of Methadone Advocates We are dedicated to educating all methadone patients, counselors, familes, employers about the benefits of methadone. We are volunteers made up of patients, ex-patients, family members, employers, counselors, providers, doctors and you. We want to end the stigma associated with being on Methadone Maintence Treatment (MMT) by educating both patients…